Lobbyist Public Search Mass. state house
Records prior to registration year 2005 are not available online.

Contact the Lobbyist Division here for assistance.
Search data is collected from registration records and disclosure reports submitted by lobbyists, lobbying entities, and their clients. Massachusetts General Law requires any party providing or retaining lobbying services to register annually, and submit disclosure reports twice a year.
Your comments are welcome:  submit feedback
Account summary
Search detail for: Park Street Strategies, LLC
Registration year: 2021
Registration type: Lobbyist Entity
Address: 121 Mount Vernon Street Boston, MA, 02108 US / 617-981-0015
Lobbyist information Amount
John F.X. Heffernan $130,000.00
Employed Terminated
01/01/2021
 
Total salaries paid:      $130,000.00
Client information Amount
Bastion Elevate $18,000.00
Employed Terminated Details about your lobbyist or lobbyist entity's efforts
03/16/2021 Issues related to marketing and communications opportunities in Massachusetts
 
Biotechnology Innovation Organization (BIO) $54,000.00
Employed Terminated Details about your lobbyist or lobbyist entity's efforts
01/01/2021 All Legislation and Executive Branch activities in the Commonwealth including, but not limited to, agriculture, health care, taxation, and other issues pertaining to biotechnology
 
Horizon Therapeutics USA, Inc. $72,000.00
Employed Terminated Details about your lobbyist or lobbyist entity's efforts
01/01/2021 Legislation, regulations, and issues related to health care and the pharmaceutical industry.
 
Massachusetts Biotechnology Council $120,000.00
Employed Terminated Details about your lobbyist or lobbyist entity's efforts
01/01/2021 Any and all legislation and regulations pertaining to the healthcare system; Any issue that impacts a biopharmaceutical company's ability to market or sell its products in all sectors and markets in the Commonwealth; any policy or proposal that seeks to limit or restrict unfettered patient access to innovative medicines and therapies in the Commonwealth; implementation of Chapter 224 the Acts of 2012, health care reform, drug innovation, pharmaceuticals, recycling and disposal policies, provider and industry practices related to pharmaceuticals, drug pricing, drug transparency, prescribing, dispensing and monitoring controlled substances and related policies, patient access and prescribing related policies, Massachusetts Life Sciences Center, research and development, taxation policies, drug safety, recycling and disposal policies green bio policies. Any and all legislation, regulation, policy matters before the legislature or executive branch including the Executive Offices of the Governor and Lieutenant Governor, Executive Office of Health & Human Services, Department of Public Health, Division of Insurance, MassHealth and related matters to the Office of the Attorney General, Center for Health Information and Analysis and the Health Policy Commission.
 
PTC Therapeutics $55,000.00
Employed Terminated Details about your lobbyist or lobbyist entity's efforts
02/10/2021 Relationship building with members of the Massachusetts legislature to discuss rare diseases, patient access to therapies and companies economic impact in Massachusetts.
 
Sage Therapeutics $66,000.00
Employed Terminated Details about your lobbyist or lobbyist entity's efforts
01/01/2021 All matters in the Commonwealth related to pharmaceuticals, healthcare, mental health issues.
 
UCB, Inc. $45,000.00
Employed Terminated Details about your lobbyist or lobbyist entity's efforts
01/01/2021 Any issue that impacts a biopharmaceutical company's ability to market or sell its products in all sectors/markets in the Commonwealth; any laws or regulations that impose or levy taxes upon a biopharmaceutical company doing business in the Commonwealth; and, any laws or regulations which provided incentives or disincentives to biopharmaceutical companies conducting research in the Commonwealth
 
Total salaries received:      $430,000.00
Expenditures Amount
Operating Expenses $24,577.44
Total expenses:      $24,577.44
Registration details

Disclosure Report details


Close this page